Wordt geladen...
Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists
The diverse actions of the incretin hormone glucagon-like peptide (GLP)-1 include insulinotropic, beta-cell preservative, cardioprotective and vasodilatory effects. This spectrum makes GLP-1 an appealing therapeutic option for patients with type 2 diabetes. However, its rapid metabolism by the enzym...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SBDR - Society for Biomedical Diabetes Research
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2836196/ https://ncbi.nlm.nih.gov/pubmed/20043037 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1900/RDS.2009.6.247 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|